Does DALFAMPRIDINE Cause Mobility decreased? 2,512 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,512 reports of Mobility decreased have been filed in association with DALFAMPRIDINE (Dalfampridine). This represents 4.5% of all adverse event reports for DALFAMPRIDINE.
2,512
Reports of Mobility decreased with DALFAMPRIDINE
4.5%
of all DALFAMPRIDINE reports
14
Deaths
262
Hospitalizations
How Dangerous Is Mobility decreased From DALFAMPRIDINE?
Of the 2,512 reports, 14 (0.6%) resulted in death, 262 (10.4%) required hospitalization, and 4 (0.2%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DALFAMPRIDINE. However, 2,512 reports have been filed with the FAERS database.
What Other Side Effects Does DALFAMPRIDINE Cause?
Gait disturbance (8,780)
Drug ineffective (6,794)
Fall (5,554)
Therapy cessation (4,580)
Fatigue (3,778)
Balance disorder (3,753)
Multiple sclerosis relapse (3,322)
Condition aggravated (3,240)
Dizziness (2,959)
Urinary tract infection (2,757)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which DALFAMPRIDINE Alternatives Have Lower Mobility decreased Risk?
DALFAMPRIDINE vs DALTEPARIN
DALFAMPRIDINE vs DAMOCTOCOG ALFA PEGOL
DALFAMPRIDINE vs DANAPAROID
DALFAMPRIDINE vs DANAZOL
DALFAMPRIDINE vs DANICOPAN